BEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) After Failure of mTOR Inhibitor Therapy.
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
A Phase I, Exploratory, Intra-patient Dose Escalation Study to Investigate the Preliminary Safety, Pharmacokinetics, and Anti-tumor Activity of Pasireotide (SOM230) s.c.Followed by Pasireotide LAR in Patients With Metastaticmelanoma or Metastatic Merkel Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Phase II, Single-Center, Oral Panobinostat in Combination With Lenalidomide and Dexamethasone in Multiple Myeloma (MM)
- Status
- COMPLETED
- Phase
- PHASE2
Observational Study of Real World Effectiveness Data and Safety in Patients Receiving Pazopanib With Advanced or Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Safety and Efficacy of Vildagliptin Versus NPH Insulin add-on to Glimepiride in Type 2 Diabetes Mellitus Patients.
- Status
- COMPLETED
- Phase
- PHASE4
Comparison of a Tacrolimus Hexal® Based Regimen Versus a Prograf® Based Regimen in de Novo Renal Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE4
16 Week Efficacy and 5 Year Long Term Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Ankylosing Spondylitis
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy of 5 Weeks of Treatment With BGG492 in Patients With Spasticity Due to Multiple Sclerosis
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of Oral CFG920 in Patients With Castration Resistant Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Pasireotide LAR in Patients With Castration Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Tolerability and Efficacy of LCZ696 in Japanese Severe Hypertensive Patients
- Status
- COMPLETED
- Phase
- PHASE3
An Open-label, Randomized Phase II Study to Evaluate the Efficacy of AUY922 vs Pemetrexed or Docetaxel in NSCLC Patients With EGFR Mutations
- Status
- TERMINATED
- Phase
- PHASE2
MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)
- Status
- COMPLETED
- Phase
- PHASE2
An Exploratory Haemodynamic Study in Patients With Compensated Cirrhosis and Portal Hypertension
- Status
- COMPLETED
- Phase
- PHASE2
4 Year Extension Study of Efficacy and Safety of Secukinumab in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Judging the Efficacy of Secukinumab in Patients With Psoriasis Using AutoiNjector: a Clinical Trial Evaluating Treatment Results (JUNCTURE)
- Status
- COMPLETED
- Phase
- PHASE3
The Everolimus-Transplant Exit Strategy Trial (E-TEST)
- Status
- TERMINATED
- Phase
- PHASE3